Shopping Cart
Remove All
Your shopping cart is currently empty
Tolmetin sodium dihydrate is a potent non-steroidal anti-inflammatory drug (NSAID) that acts as an orally active cyclooxygenase (COX) inhibitor. Tolmetin sodium dihydrate demonstrates inhibitory concentration (IC50) values of 0.35 μM and 0.82 μM for human COX-1 and COX-2 enzymes, respectively, and is widely used as a reference compound for studying the biochemical and pharmacodynamic properties of NSAID-mediated prostaglandin synthesis inhibition.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | $30 | - | In Stock | |
| 100 mg | $37 | - | In Stock | |
| 500 mg | $79 | - | In Stock | |
| 1 g | $113 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $39 | - | In Stock |
| Description | Tolmetin sodium dihydrate is a potent non-steroidal anti-inflammatory drug (NSAID) that acts as an orally active cyclooxygenase (COX) inhibitor. Tolmetin sodium dihydrate demonstrates inhibitory concentration (IC50) values of 0.35 μM and 0.82 μM for human COX-1 and COX-2 enzymes, respectively, and is widely used as a reference compound for studying the biochemical and pharmacodynamic properties of NSAID-mediated prostaglandin synthesis inhibition. |
| Targets&IC50 | COX-2 (human):0.82 μM, COX-1 (human):0.35 μM |
| In vitro | Tolmetin sodium dihydrate (0.25 mM) showed no inhibitory effect on lipid peroxidation in rat brain homogenates [3]. Tolmetin sodium dihydrate (0.001-100 μM) exhibited dose-dependent anticancer activity against HT-29 colon carcinoma cells [4]. Tolmetin sodium dihydrate (0-100 μM) had no significant effect on osteoblast growth [5]. |
| In vivo | In male Wistar rats, the ulcerogenic effect of Tolmetin sodium dihydrate (30, 100 mg/kg, oral administration) reached its peak 4 hours after a single dose, while this effect significantly weakened after repeated administration for 3 and 14 days [2]. Pretreatment with Tolmetin sodium dihydrate (5 mg/kg, twice daily) for 5 consecutive days effectively alleviated quinolinic acid (QA)-induced neurotoxicity [3]. |
| Molecular Weight | 315.3 |
| Formula | C15H18NNaO5 |
| Cas No. | 64490-92-2 |
| Smiles | O=C(CC1=CC=C(N1C)C(C2=CC=C(C)C=C2)=O)[O-].[Na+].O.O |
| Relative Density. | no data available |
| Color | Yellow |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 10 mg/mL (31.72 mM), Sonication is recommended. H2O: ≥ 80 mg/mL, Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.